Management

 

Richard J. Klein, DDS, DICOI, Chairman of the Board/CEO, has a wide range of professional experience, as well as an impressive medical and surgical background.  He is the sole or co-owner of several successful businesses, including Now Dental of Suffolk, a well-established multi-specialty dental practice in Smithtown, NY.  As an angel investor in Biohorizons, Dr. Klein was instrumental in the establishment of a European distribution channel, and in the support of this channel through professional academic training centers. Dr. Klein has provided the seed capital necessary to build and support Kantian.

Jonathan E. Klein, BS, President, received his B.S. in Business Administration with a focus in Marketing and Management from The University of Albany in 2005.  From 2006-2010, Mr. Klein gained valuable experience in corporate sales, marketing and business development with Metropolitan Life, JP Morgan Chase and Wachovia. He has also worked with various companies as a marketing consultant, specializing in customer acquisition, prior to taking on a full time role with Kantian.  Mr. Klein is primarily responsible for the establishment of the Company’s various marketing & business development initiatives referenced herein, as well as the day-to-day management of the Company.
Richard J. Klein, DDS, DICOI, Chairman of the Board/CEO, has a wide range of professional experience, as well as an impressive medical and surgical background.  He is the sole or co-owner of several successful businesses, including Now Dental of Suffolk, a well-established multi-specialty dental practice in Smithtown, NY.  As an angel investor in Biohorizons, Dr. Klein was instrumental in the establishment of a European distribution channel, and in the support of this channel through professional academic training centers. Dr. Klein has provided the seed capital necessary to build and support Kantian.

Jonathan E. Klein, BS, President, received his B.S. in Business Administration with a focus in Marketing and Management from The University of Albany in 2005.  From 2006-2010, Mr. Klein gained valuable experience in corporate sales, marketing and business development with Metropolitan Life, JP Morgan Chase and Wachovia. He has also worked with various companies as a marketing consultant, specializing in customer acquisition, prior to taking on a full time role with Kantian.  Mr. Klein is primarily responsible for the establishment of the Company’s various marketing & business development initiatives referenced herein, as well as the day-to-day management of the Company.

Richard J. Klein, DDS, DICOI, Chairman of the Board/CEO, Co-Founder & Seed Investor, has a wide range of professional experience, as well as an impressive medical and surgical background.  He is a serial entrepreneur and investor in multiple start-ups and early stage companies over the last 30 years.  Dr. Klein was instrumental in the success of professional education programs (FQA, Spain) which supported the international growth of BioHorizons, Inc. (BHZN).  In addition to providing the seed capital necessary to build and support Kantian, Dr. Klein serves as the Company's Chairperson and Chief Executive Officer.

 

Jonathan E. Klein, BS, President, Co-Founder, received his B.S. in Business Administration with a focus in Marketing and Management from The University of Albany in 2005.  From 2006-2010, Mr. Klein gained valuable experience in corporate sales, marketing and business development with Metropolitan Life, JP Morgan Chase and Wachovia. He has also worked as a digital marketing consultant, prior to taking on a full time role with Kantian.  Mr. Klein is primarily responsible for the establishment of the Company’s various marketing and business development initiatives, as well as the day-to-day management and growth of the Company.



Business Advisory Board


Edwin D. Schindler, Esq., Patent Counsel, is a well-established and experienced Patent Attorney with a strong background in chemistry.  As of today's date, he is listed as Attorney on 632 U.S. patents, having prosecuted, in whole or in part, at least 2,000 U.S. patent applications for his own clients and clients of other firms, both domestically and in Europe, Australia, Israel, Japan and Singapore.  He is also listed as Attorney of Record for 310 trademark applications and has prosecuted many more for other firms over the years. Mr. Schindler provides legal services for Kantian, including the writing, prosecution, defense and filing of patent applications.

 

David R. O’Connell, BS, D2C Marketing & Business Development Consultant, is focused in the areas of interactive advertising, internet retail, direct response marketing, and business analytics.  He is experienced at developing and executing revenue growth strategies, and has expertise in customer acquisition via online media channels: search engine marketing (paid & SEO), e-mail marketing, online display advertising, and social media.  Mr. O’Connell serves as a strategic advisor for Kantian’s direct-to-consumer test marketing program and distribution channel.


Scientific Advisory Board


Elizabeth Boon, PhD, Chemist & Technical Consultant, is an Associate Professor of Chemistry at Stony Brook University.  Research in her laboratory focuses on understanding NO signaling in bacteria from a molecular, to a community-level, and employing this new knowledge to advance human health, prosperity and welfare.  She received her PhD in Chemistry from the California Institute of Technology in 2002.  From 2003-2006, Dr. Boon was a NIH Postdoctoral Fellow at the University of California.  In 2006, she was a founding scientist for Omniox, Inc., which is a biotechnology company that develops oxygen delivery therapeutics.  In 2011, Dr. Boon was elected a Kavli Fellow by the National Academy of Sciences.  Dr. Boon has contributed to 35 peer-reviewed scientific papers, 5 patents and patent applications, and has professional memberships with a variety of scientific organizations, for which she is a regular organizer and presenter.

 

Lorrence H. Green, PhD, Microbiologist, is President of Westbury Diagnostics, Inc., a full service organization which works with clients to generate solutions to problems in the bioscience industry.  He earned a Ph.D. in Cell and Molecular Biology from Indiana University.  He followed this with three years of recombinant DNA and genetic research at Harvard University.  Dr. Green has served as Director of New Product Development and Product Support for Analytab Products, a major manufacturer of in vitro diagnostic test kits.  During his twelve years with that company, he invented and manufactured over 40 diagnostic test kits.  In addition to running Westbury Diagnostics, Dr. Green routinely gives lectures at four universities, and has co-edited the recently released “CRC Practical Handbook of Microbiology, second edition”.  Westbury Diagnostics provides valuable microbiological testing and other related services to Kantian.